Related references
Note: Only part of the references are listed.Mitotic Activity in Glioblastoma Correlates with Estimated Extravascular Extracellular Space Derived from Dynamic Contrast-Enhanced MR Imaging
S. J. Mills et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas
Julio Arevalo-Perez et al.
JOURNAL OF NEUROIMAGING (2016)
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma
Sina Burth et al.
NEURO-ONCOLOGY (2016)
Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI
S. Bisdas et al.
CLINICAL NEURORADIOLOGY (2016)
The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival
Y. S. Choi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Prospective glioma grading using single-dose dynamic contrast-enhanced perfusion MRI
K. K. Jain et al.
CLINICAL RADIOLOGY (2015)
The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging
Zhong Zheng Jia et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas
Julio Arevalo-Perez et al.
JOURNAL OF NEUROIMAGING (2015)
Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy: Differentiation of True Progression from Pseudoprogression with Quantitative Dynamic Contrast-enhanced MR Imaging
Tae Jin Yun et al.
RADIOLOGY (2015)
Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging
Xiaoguang Li et al.
CANCER IMAGING (2015)
Preoperative Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas
T. B. Nguyen et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1- and T2*-based bolus techniques
David Bonekamp et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab
Philipp Kickingereder et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging
Seunghyun Lee et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
Improving tumour heterogeneity MRI assessment with histograms
N. Just
BRITISH JOURNAL OF CANCER (2014)
Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes
Rajiv Mangla et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Dynamic Contrast Enhanced MRI Parameters and Tumor Cellularity in a Rat Model of Cerebral Glioma at 7 T
Madhava P. Aryal et al.
MAGNETIC RESONANCE IN MEDICINE (2014)
Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral nnicroenvironment and is predictive of patient outcome
Randy L. Jensen et al.
NEURO-ONCOLOGY (2014)
Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach
Anna Falk et al.
NEURORADIOLOGY (2014)
Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: Potential to guide treatment? A systematic review
Jonathan M. Bernstein et al.
ORAL ONCOLOGY (2014)
IDH1 and IDH2 Mutations in Gliomas
Adam L. Cohen et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Low-grade and anaplastic oligodendrogliomas: Differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging
Zhongzheng Jia et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Long-term survival of patients with glioblastoma multiforme (GBM)
Nicolas R. Smoll et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Analysis of parametric histogram from dynamic contrast-enhanced MRI: application in evaluating brain tumor response to radiotherapy
Shin-Lei Peng et al.
NMR IN BIOMEDICINE (2013)
IDH1/IDH2 Mutations Define the Prognosis and Molecular Profiles of Patients with Gliomas: A Meta-Analysis
Peng Zou et al.
PLOS ONE (2013)
Reproducibility of Dynamic Contrast-enhanced MR Imaging Part II. Comparison of Intra- and Interobserver Variability with Manual Region of Interest Placement versus Semiautomatic Lesion Segmentation and Histogram Analysis
Tobias Heye et al.
RADIOLOGY (2013)
Correlation between Cerebral Blood Volume Measurements by Perfusion-Weighted Magnetic Resonance Imaging and Two Year Progression-Free Survival in Gliomas
M. V. Spampinato et al.
NEURORADIOLOGY JOURNAL (2013)
Do Imaging Biomarkers Relate to Outcome in Patients Treated with VEGF Inhibitors?
James P. B. O'Connor et al.
CLINICAL CANCER RESEARCH (2012)
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging
M. O. Leach et al.
EUROPEAN RADIOLOGY (2012)
Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas
Na Zhang et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)
Moving toward molecular classification of diffuse gliomas in adults
Brett J. Theeler et al.
NEUROLOGY (2012)
Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers
Rishi Awasthi et al.
NEURORADIOLOGY (2012)
Interpretation and applicability of empirical tissue enhancement metrics in dynamic contrast-enhanced MRI based on a multiple pathway model
T. S. Koh et al.
PHYSICS IN MEDICINE AND BIOLOGY (2012)
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
Teri N. Kreisl et al.
NEURO-ONCOLOGY (2011)
Candidate Biomarkers of Extravascular Extracellular Space: A Direct Comparison of Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced MR Imaging-Derived Measurement of the Volume of the Extravascular Extracellular Space in Glioblastoma Multiforme
S. J. Mills et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2010)
Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
J. J. C. Verhoeff et al.
ANNALS OF ONCOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Diagnostic and prognostic markers in gliomas
Francois Ducray et al.
CURRENT OPINION IN ONCOLOGY (2009)
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
Suja Saraswathy et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
High-Resolution Longitudinal Assessment of Flow and Permeability in Mouse Glioma Vasculature: Sequential Small Molecule and SPIO Dynamic Contrast Agent MRI
M. M. Pike et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Glioma vascularity correlates with reduced patient survival and increased malignancy
Stephen M. Russell et al.
SURGICAL NEUROLOGY (2009)
Prognostic value of perfusion MR imaging of high-grade astrocytomas: Long-term follow-up study
T. Hirai et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2008)
Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates
Michael Aref et al.
MAGNETIC RESONANCE IMAGING (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI
Matthew R. Orton et al.
PHYSICS IN MEDICINE AND BIOLOGY (2008)
Gliomas: Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging
Meng Law et al.
RADIOLOGY (2008)
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI
Geoff J. M. Parker et al.
MAGNETIC RESONANCE IN MEDICINE (2006)
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
MO Leach et al.
BRITISH JOURNAL OF CANCER (2005)
Share Paper
